Lifeboat Foundation

One Danish city is exploring a new concert alternative.

In a bid to ensure physical distancing at COVID-19 care facility in Amritsar, a robotic trolley ‘carbeot’ has been deployed to provide essentials like medicines, food to coronavirus patients.

With the Space Launch System’s inaugural test flight now officially delayed to November 2021, NASA says work halted by the coronavirus pandemic will resume within weeks to prepare for the first test-firing of the SLS core stage at the Stennis Space Center in Mississippi.

The last official schedule from NASA had the first SLS test launch in March 2021, but managers have said for months that schedule was no longer achievable. After a thorough review, NASA says the first SLS launch — named Artemis 1 — is now planned in November of next year.

The most powerful launch vehicle since the Apollo-era Saturn 5 moon rocket, the Space Launch System will carry an unpiloted Orion crew capsule into space. The Orion spaceship will orbit the moon to demonstrate the capsule’s capabilities and performance before NASA commits to flying astronauts around the moon on the second SLS/Orion flight in late 2022 or early 2023.

What did Hubble discover during its 30th year in space? Take a look at some of the highlights as it embarks on another year of exploration! #Hubble30

A North Korean defector-turned-South Korea lawmaker claimed Friday he is “99 percent” sure that Kim Jong Un died after surgery — amid swirling speculation about the dictator’s condition.

Ji Seong-ho, who earned a proportional representation seat of a minor party in the country’s April 15 elections, told Yonhap News Agency he believes Kim died after his recent surgery and that North Korea will announce it this weekend.

“I’ve wondered how long he could have endured after cardiovascular surgery. I’ve been informed that Kim died last weekend,” Ji told the outlet. “It is not 100 percent certain, but I can say the possibility is 99 percent. North Korea is believed to be grappling with a complicated succession issue.”

Question: When you’ve designed the world’s most efficient metamaterial, one that could change the way cars, planes and even space exploration vehicles are built, is mostly air yet reaches the theoretical bounds for stiffness and strength and can equally resist forces coming from any direction, what do you do next?

Answer: You break it.

At least, that’s what a team of material scientists including Jonathan Berger of UC Santa Barbara and Jens Bauer of UC Irvine did. Their goal? To learn what boundaries could be pushed with a novel metamaterial called plate-nanolattice. The research findings are published in a paper in the journal Nature Communications (“Plate-nanolattices at the theoretical limit of stiffness and strength”).

“According to WAM, stem cells are extracted from the patient’s blood and then reintroduced in an “activated” state to the lungs through inhalation after being nebulized into a fine mist.

ADSCC researchers said the mist had a therapeutic effect, helping to regenerate lung cells and alter the response of the immune system to stop it from overreacting to the COVID-19 infection and causing more damage to healthy cells.

The treatment has undergone and successfully passed the first stage of clinical trials with further tests to demonstrate its effectiveness being carried out over the next two weeks.”

Continue reading “Abu Dhabi stem cell center develops ‘promising’ new COVID-19 treatment” »

WASHINGTON — Michael Fleming never got to say goodbye to his father. He didn’t know his dad was fading away on a ventilator, diagnosed with coronavirus at the federal prison where he was serving time for a drug charge.

His father, also named Michael, was held at FCI Terminal Island in Los Angeles and died April 19. At least half the population there has tested positive, the largest known hot spot in the federal prison system. But the first word the family received of the father’s illness was the day he died, from a prison chaplain asking if the body should be cremated and where the ashes should be sent.

“They just left us all in the dark,” Fleming said in an interview with The Associated Press. “We had to find out from the news what the actual cause of death was. It was kind of screwed up.”

Coronavirus disease 2019 (COVID-19) is a current pandemic infection caused by a positive-sense RNA virus named the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The particularly infectious capacity of the virus, along with mortality rates ranging from 1% to above 5%, has raised concerns across the globe.¹ Older patients with comorbid conditions including pulmonary disease, cardiac disease, kidney disease, diabetes, and hypertension have been associated with even higher mortality rates, suggesting particularly susceptible populations.

The increased mortality and morbidity of COVID-19 in patients with hypertension is an association that has been observed in a number of initial epidemiological studies outlining the characteristics of the COVID-19 epidemic in China. Wu et al² found hypertension to have a hazard ratio of 1.70 for death and 1.82 for acute respiratory distress syndrome in 201 patients with COVID-19. Zhou et al³ found hypertension to have a hazard ratio of 3.05 for in-hospital mortality in 191 patients with COVID-19.

Neither of these studies^2,3 adjusted for confounding variables and thus it remains unclear if this association is related to the pathogenesis of hypertension or another associated comorbidity or treatment. There has been a growing concern that this association with hypertension is confounded by treatment with specific antihypertensive medications: angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs).